Heart failure secrets revealed? new study dives deep into genes and proteins

NCT ID NCT07158086

Not yet recruiting Knowledge-focused Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to better understand heart failure by deeply analyzing the genes, proteins, and other molecules in patients' blood and tissues. Researchers will enroll 500 adults with heart failure and combine detailed clinical data with advanced lab tests. The goal is to find molecular patterns that could predict disease progression and suggest new ways to treat heart failure in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify new biomarkers to predict heart failure progression and point toward future treatments.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all heart failure patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Edema heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE HEART FAILURE (FOR EXAMPLE, FLUID OVERLOAD)

Contacts and locations

Locations

University Hospital of Zurich

Zurich, 8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.